CD163 and pulmonary arterial hypertension: In particular, patients with elevated serum sCD163 levels showed not only higher right ventricular systolic pressure and lower carbon monoxide diffusing capacity levels [235], but also a significantly higher sPAP [236], suggesting a possible association between sCD163 and the severity of disease-related PAH.